JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, vol.8, no.12, pp.1601-1608, 2014 (SCI-Expanded)
Article / Article
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Van Yüzüncü Yıl University Affiliated:
Introduction: Although pegylated interferons (pegIFNs) alpha-2a and alpha-2b have been used in chronic hepatitis B (CHB) treatment for many years, there are few studies concerning predictors of sustained virologic response (SVR) to pegIFN therapy. In this study, we aimed to investigate the predictors of response to pegIFN treatment in cases with HBeAg-negative CHB infection.